-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 U8BYmlyUEw1tPhLa6e+KbZ+/hKPkf6x2pqk2LeIQuou3hQAdan8vhvy0YxuWoOov
 ixoUEx+23SNV4FBKeSuAyw==

<SEC-DOCUMENT>0001181431-08-037491.txt : 20080606
<SEC-HEADER>0001181431-08-037491.hdr.sgml : 20080606
<ACCEPTANCE-DATETIME>20080606175335
ACCESSION NUMBER:		0001181431-08-037491
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080605
FILED AS OF DATE:		20080606
DATE AS OF CHANGE:		20080606

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCOLR Pharma, Inc.
		CENTRAL INDEX KEY:			0000934936
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				911689591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3625 132ND AVENUE SE
		STREET 2:		SUITE 400
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98006
		BUSINESS PHONE:		4253730171

	MAIL ADDRESS:	
		STREET 1:		3625 132ND AVENUE SE
		STREET 2:		SUITE 400
		CITY:			BELLEVUE
		STATE:			WA
		ZIP:			98006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCOLR INC
		DATE OF NAME CHANGE:	20020813

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUTRACEUTIX INC
		DATE OF NAME CHANGE:	19980713

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CADDY SYSTEMS INC
		DATE OF NAME CHANGE:	19951102

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MORRA BRUCE S
		CENTRAL INDEX KEY:			0001190744

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31982
		FILM NUMBER:		08886685

	MAIL ADDRESS:	
		STREET 1:		C/O WEST PHARMACEUTIACL SERVICES
		STREET 2:		101 GORDON DRIVE
		CITY:			LIONVILLE
		STATE:			PA
		ZIP:			19341
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd207487.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-06-05</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000934936</issuerCik>
        <issuerName>SCOLR Pharma, Inc.</issuerName>
        <issuerTradingSymbol>DDD</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001190744</rptOwnerCik>
            <rptOwnerName>MORRA BRUCE S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O SCOLR PHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>3625 132ND AVE. SE, SUITE 400</rptOwnerStreet2>
            <rptOwnerCity>BELLEVUE</rptOwnerCity>
            <rptOwnerState>WA</rptOwnerState>
            <rptOwnerZipCode>98006</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.17</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-06-05</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>17500</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2018-06-04</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>17500</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>17500</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The option shall vest in twelve equal monthly installments beginning June 6, 2008.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Bruce S. Morra Alan M. Mitchel, Attorney-in-Fact</signatureName>
        <signatureDate>2008-06-06</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----